• Is “Leptin Resistance” Another Key Resistance to Manage Type 2 Diabetes? 

      Salazar, Juan; Chávez-Castillo, Mervin; Rojas, Joselyn; Ortega, Ángel; Nava, Manuel; Pérez, José; Rojas, Milagros; Espinoza, Cristobal; Chacín, Maricarmen; Herazo, Yaneth; Angarita, Lissé; Rojas, Diana Marcela; D'Marco, Luis; Bermúdez, Valmore (Bentham Science Publishers, 2020)
      Although novel pharmacological options for the treatment of type 2 diabetes mellitus (DM2) have been observed to modulate the functionality of several key organs in glucose homeostasis, successful regulation of insulin ...